{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:51:57Z","timestamp":1791571917164,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.numecd.2026.104817","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T23:10:01Z","timestamp":1780787401000},"page":"104817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Liver fibrosis, but not steatosis, provides incremental prognostic value beyond cardiovascular-kidney-metabolic staging"],"prefix":"10.1016","volume":"36","author":[{"given":"Ji Hye","family":"Heo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Eun","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeonggyu","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5630-2145","authenticated-orcid":false,"given":"Ki-Chul","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2026.104817_bib1","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American heart association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2026.104817_bib2","article-title":"Association between systemic immune-inflammation index and cardiovascular-kidney-metabolic syndrome","volume":"14","author":"Gao","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.numecd.2026.104817_bib3","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2026.104817_bib4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2026.104817_bib5","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jhep.2020.01.013","article-title":"NAFLD as a driver of chronic kidney disease","volume":"72","author":"Byrne","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2026.104817_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1433857","article-title":"Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases","volume":"12","author":"Sandireddy","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.numecd.2026.104817_bib7","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/gut.2010.216077","article-title":"Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease","volume":"59","author":"McPherson","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.numecd.2026.104817_bib8","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/gutjnl-2018-317666","article-title":"Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung health study","volume":"68","author":"Chang","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.numecd.2026.104817_bib9","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and validation of the American heart Association's PREVENT equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2026.104817_bib10","doi-asserted-by":"crossref","first-page":"801","DOI":"10.21037\/hbsn-23-558","article-title":"Comparative associations of non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease with risk of incident chronic kidney disease: a cohort study","volume":"13","author":"Heo","year":"2024","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.numecd.2026.104817_bib11","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.2337\/dc24-S002","article-title":"Diagnosis and classification of diabetes: standards of care in Diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2026.104817_bib12","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.jacc.2025.05.007","volume":"86","author":"Jones","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2026.104817_bib13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.7570\/jomes23031","article-title":"Diagnosis of obesity: 2022 update of clinical practice guidelines for obesity by the Korean society for the study of obesity","volume":"32","author":"Haam","year":"2023","journal-title":"J Obes Metab Syndr"},{"key":"10.1016\/j.numecd.2026.104817_bib14","doi-asserted-by":"crossref","DOI":"10.35371\/aoem.2022.34.e4","article-title":"The effect of long working hours on developing type 2 diabetes in adults with prediabetes: the kangbuk samsung cohort study","volume":"34","author":"Seo","year":"2022","journal-title":"Ann Occup Environ Med"},{"key":"10.1016\/j.numecd.2026.104817_bib15","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.numecd.2026.104817_bib16","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/gut.2010.216077","article-title":"Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease","volume":"59","author":"McPherson","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.numecd.2026.104817_bib17","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.3346\/jkms.2017.32.11.1764","article-title":"Using the national health information database of the national health insurance service in Korea for monitoring mortality and life expectancy at national and local levels","volume":"32","author":"Bahk","year":"2017","journal-title":"J Kor Med Sci"},{"key":"10.1016\/j.numecd.2026.104817_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.101843","article-title":"Prevalence and mortality association of different stages of cardiovascular-kidney-metabolic syndrome","volume":"4","author":"Chen","year":"2025","journal-title":"JACC Adv"},{"key":"10.1016\/j.numecd.2026.104817_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7570\/jomes22023","article-title":"Metabolic syndrome: a warning sign of liver fibrosis","volume":"31","author":"Seo","year":"2022","journal-title":"J Obes Metab Syndr"},{"key":"10.1016\/j.numecd.2026.104817_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2025.101049","article-title":"Prevalence and long-term outcomes of NAFLD and cardiovascular-kidney-metabolic health in the United States","volume":"23","author":"Liu","year":"2025","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.numecd.2026.104817_bib21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12875-025-03039-x","article-title":"Prevalence of advanced fibrosis risk using FIB-4 in patients with type 2 diabetes and its associated factors: a cross-sectional study in a primary care unit of a university hospital in southern Thailand","volume":"26","author":"Ananchaisarp","year":"2025","journal-title":"BMC Prim Care"},{"key":"10.1016\/j.numecd.2026.104817_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfaf260","article-title":"The impact of metabolic dysfunction-associated steatotic liver disease (MASH) on the high risk of cardiovascular disease in CKD: interconnections and management","volume":"18","author":"Moncho","year":"2025","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.numecd.2026.104817_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2025.1675899","article-title":"Cardiovascular-kidney-metabolic progression associated with major adverse liver outcomes: mediating roles of plasma metabolites","volume":"12","author":"Liang","year":"2025","journal-title":"Front Nutr"},{"key":"10.1016\/j.numecd.2026.104817_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/eurjpc\/zwaf396","article-title":"Hepatic steatosis in cardiovascular-kidney-metabolic syndrome: fatty liver index as a predictor of cardiovascular outcomes","author":"Kim","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.numecd.2026.104817_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102292","article-title":"Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study","volume":"65","author":"Moon","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.numecd.2026.104817_bib26","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.numecd.2026.104817_bib27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12916-024-03366-3","article-title":"Hepatic steatosis, metabolic dysfunction and risk of mortality: findings from a multinational prospective cohort study","volume":"22","author":"Mayen","year":"2024","journal-title":"BMC Med"},{"key":"10.1016\/j.numecd.2026.104817_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26146962","article-title":"Lipid accumulation and insulin resistance: bridging metabolic dysfunction-associated fatty liver disease and chronic kidney disease","volume":"26","author":"Cao","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.numecd.2026.104817_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/biom15020213","article-title":"From cardiovascular-kidney-metabolic syndrome to cardiovascular-renal-hepatic-metabolic syndrome: proposing an expanded framework","volume":"15","author":"Theodorakis","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.numecd.2026.104817_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207923","article-title":"Validity of ultrasonography to assess hepatic steatosis compared to magnetic resonance spectroscopy as a criterion method in older adults","volume":"13","author":"De Lucia Rolfe","year":"2018","journal-title":"PLoS One"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475326002796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475326002796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:08:00Z","timestamp":1791569280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475326002796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0939475326002796"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2026.104817","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver fibrosis, but not steatosis, provides incremental prognostic value beyond cardiovascular-kidney-metabolic staging","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2026.104817","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104817"}}